Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Diffusion Pharmaceuticals Inc. | dffn20171231_10k.htm |
| EX-32.1 - EXHIBIT 32.1 - Diffusion Pharmaceuticals Inc. | ex_108107.htm |
| EX-31.2 - EXHIBIT 31.2 - Diffusion Pharmaceuticals Inc. | ex_108106.htm |
| EX-31.1 - EXHIBIT 31.1 - Diffusion Pharmaceuticals Inc. | ex_108105.htm |
| EX-23.1 - EXHIBIT 23.1 - Diffusion Pharmaceuticals Inc. | ex_108150.htm |
| EX-10.5 - EXHIBIT 10.5 - Diffusion Pharmaceuticals Inc. | ex_108103.htm |
|
SUBSIDIARIES OF THE REGISTRANT
|
Exhibit 21.1
|
|
|
Name of Subsidiary |
State or Other Jurisdiction of Incorporation or Organization |
Direct or Indirect Ownership Interest by RestorGenex |
|
Canterbury Laboratories, LLC |
DE |
100% |
|
Hygeia Therapeutics, Inc. |
DE |
100% |
|
Paloma Pharmaceuticals, Inc. |
DE |
100% |
|
VasculoMedics, Inc. |
DE |
100% |
|
Diffusion Pharmaceuticals LLC |
VA |
100% |